PhytoHealth Corporation (TPE:4108)
Taiwan · Delayed Price · Currency is TWD 12.40
-0.15 (-1.20%)
May 29, 2026, 1:30 PM CST
PhytoHealth Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -59.13 | -58.2 | -73.5 | -47.12 | -79.41 | -77.72 |
Depreciation & Amortization | 48 | 48.65 | 52.96 | 52.77 | 52.09 | 52.43 |
Other Amortization | 0.42 | 0.42 | 0.38 | 0.34 | 0.35 | 0.38 |
Loss (Gain) From Sale of Assets | 0.17 | 0.22 | 0.19 | 0.17 | 0.01 | 0.08 |
Loss (Gain) From Sale of Investments | -1.28 | -1.45 | -0.1 | -0.07 | -0.07 | -0.04 |
Stock-Based Compensation | 1.19 | 1.14 | 3.23 | 0.83 | 0.86 | 7.02 |
Provision & Write-off of Bad Debts | - | - | 0 | - | -0.05 | -0.1 |
Other Operating Activities | -50.55 | -51.94 | -35.04 | -27.03 | -35.31 | -17.8 |
Change in Accounts Receivable | 5.02 | 4.23 | -4.89 | -10.17 | -5.24 | -7.43 |
Change in Inventory | 39.01 | 27.54 | 0.66 | -15.58 | -6.12 | 5.85 |
Change in Accounts Payable | -3.16 | -2.12 | 5.6 | -3.22 | 3.69 | -2 |
Change in Unearned Revenue | 0.36 | -0.06 | -1.54 | -0.61 | -2.78 | -31.61 |
Change in Other Net Operating Assets | -7.47 | -8.14 | 1.93 | -5.06 | 12.04 | 2.7 |
Operating Cash Flow | -27.42 | -39.72 | -50.13 | -54.77 | -59.95 | -68.24 |
Capital Expenditures | -5.18 | -5.54 | -4.72 | -4.91 | -1.61 | -13.22 |
Sale of Property, Plant & Equipment | - | - | - | 0.46 | - | - |
Sale (Purchase) of Intangibles | -0.33 | -0.33 | -0.33 | -0.29 | - | - |
Investment in Securities | 68.25 | 120.56 | -130.53 | 29.56 | 78.93 | -568.26 |
Other Investing Activities | -0.04 | 0.13 | 0.43 | 1.42 | -0.41 | 0.33 |
Investing Cash Flow | 62.7 | 114.82 | -135.14 | 26.25 | 76.92 | -581.15 |
Long-Term Debt Repaid | - | -11.06 | -11.4 | -10.5 | -10.53 | -10.65 |
Net Debt Issued (Repaid) | -10.95 | -11.06 | -11.4 | -10.5 | -10.53 | -10.65 |
Issuance of Common Stock | - | - | 0.63 | 1.32 | - | 700 |
Other Financing Activities | 0.03 | 0.03 | 156.01 | - | 0.01 | -7.12 |
Financing Cash Flow | -10.93 | -11.04 | 145.24 | -9.18 | -10.52 | 682.23 |
Net Cash Flow | 24.36 | 64.07 | -40.03 | -37.7 | 6.45 | 32.84 |
Free Cash Flow | -32.59 | -45.26 | -54.85 | -59.68 | -61.55 | -81.46 |
Free Cash Flow Margin | -23.52% | -33.63% | -35.72% | -36.73% | -45.44% | -48.22% |
Free Cash Flow Per Share | -0.16 | -0.23 | -0.28 | -0.30 | -0.31 | -0.42 |
Cash Interest Paid | 0.37 | 0.38 | 0.34 | 0.34 | 0.31 | 0.41 |
Cash Income Tax Paid | 0.01 | 0 | 0.01 | - | - | - |
Levered Free Cash Flow | -31.35 | -43.31 | -44.51 | -58.46 | -44.36 | -64.28 |
Unlevered Free Cash Flow | -31.12 | -43.07 | -44.3 | -58.25 | -44.17 | -64.03 |
Change in Working Capital | 33.76 | 21.45 | 1.75 | -34.65 | 1.59 | -32.5 |